Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 5, 2025
Blood
phosphorylated
(p)-tau
181
and
p-tau
217
have
been
proposed
as
accurate
biomarkers
of
Alzheimer's
disease
(AD)
pathology.
However,
blood
is
also
elevated
in
amyotrophic
lateral
sclerosis
(ALS)
without
a
clearly
identified
source.
We
measured
serum
multicentre
cohort
ALS
(n
=
152),
AD
111)
cases
controls
99)
recruited
from
four
different
centres.
Further,
we
investigated
the
existence
both
species
using
immunohistochemistry
(IHC)
mass
spectrometry
(MS)
muscle
biopsies
(IHC:
n
13,
MS:
5)
14,
one
cohort.
Serum
were
higher
patients
compared
to
controls.
IHC
MS
analyses
revealed
presence
controls,
with
samples
showing
increased
reactivity
atrophic
fibres.
could
potentially
be
used
diagnose
AD.
Language: Английский
The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4269 - 4269
Published: April 12, 2024
Iron
accumulation
in
the
brain
is
a
common
feature
of
many
neurodegenerative
diseases.
Its
involvement
spans
across
main
proteinopathies
involving
tau,
amyloid-beta,
alpha-synuclein,
and
TDP-43.
Accumulating
evidence
supports
contribution
iron
disease
pathologies,
but
delineation
its
pathogenic
role
yet
challenged
by
complex
multiple
neurotoxicity
mechanisms
supporting
reciprocal
influence
between
protein
pathology.
Here,
we
review
major
proteinopathy-specific
observations
four
distinct
hypotheses:
(1)
deposition
consequence
pathology;
(2)
promotes
(3)
protects
from
or
hinders
(4)
pathology
contribute
parallelly
to
pathogenesis.
an
essential
element
for
physiological
function,
requiring
fine
balance
levels.
Understanding
disease-related
at
more
intricate
systemic
level
critical
advancements
chelation
therapies.
Language: Английский
Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy
JAMA Neurology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 23, 2024
This
study
discusses
4-repeat
tau
seeding
in
the
skin
of
patients
with
progressive
supranuclear
palsy.
Language: Английский
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
npj Parkinson s Disease,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: June 15, 2024
Abstract
Most
neurodegenerative
diseases
lack
definitive
diagnostic
tests,
and
the
identification
of
easily
accessible
reliable
biomarkers
remains
a
critical
unmet
need.
Since
tau
protein
is
highly
expressed
in
skin
tauopathies
patients,
we
aimed
to
exploit
ultrasensitive
seeding
activity
assay
(SAA)
assess
patients
with
tauopathies.
In
this
multicentric,
case-control
study,
synucleinopathies
were
consecutively
recruited
sex-matched
healthy
controls
(HC).
Subjects
underwent
double
3
mm
biopsy
cervical
area
ankle.
Skin
tau-SAA,
using
TauK18
TauK19
as
reaction
substrates
for
4R
3R
isoforms,
score,
clinical
scales,
biochemical
morphological
characterization
SAA
end-products
evaluated.
We
analyzed
58
subjects:
24
(18
progressive
supranuclear
palsy,
PSP,
6
corticobasal
degeneration,
CBD),
20
(14
Parkinson’s
disease,
PD,
multiple
system
atrophy,
MSA),
14
HC.
PSP
CBD
showed
higher
at
both
anatomical
sites.
A
greater
sensitivity
4R-SAA
than
3R-SAA
was
observed.
tau-SAA
identified
71%
93%
specificity.
Accuracy
CBD:
vs
HC
/
PD
(AUC
0.825),
while
0.797),
MSA
(AU
0.778).
differences
according
site.
identifies
good
accuracy
can
be
used
implement
in-vivo
diagnosis
diseases.
Further
peripheral
seed
may
elucidate
structure
deposits
brain.
Language: Английский
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Eun Hae Kwon,
No information about this author
Antonia Bieber,
No information about this author
Paula Schülken
No information about this author
et al.
Journal of Neurology,
Journal Year:
2024,
Volume and Issue:
271(9), P. 6136 - 6146
Published: July 26, 2024
Increasing
evidence
indicates
a
higher
prevalence
of
polyneuropathy
(PNP)
in
Parkinson's
disease
(PD).
However,
the
involvement
large
fiber
neuropathy
PD
still
remains
poorly
understood.
Given
lack
longitudinal
data,
we
investigated
course
PNP
associated
with
PD.
Language: Английский
Autonomic dysfunction in progressive supranuclear Palsy: A retrospective study
Yichun Wang,
No information about this author
Man-qing Xie,
No information about this author
Dan Xu
No information about this author
et al.
Clinical Parkinsonism & Related Disorders,
Journal Year:
2025,
Volume and Issue:
12, P. 100310 - 100310
Published: Jan. 1, 2025
This
study
aims
to
investigate
the
characteristics
of
autonomic
dysfunction
in
progressive
supranuclear
palsy
(PSP)
compared
Parkinson's
disease
(PD)
and
multiple
system
atrophy-parkinsonian
type
(MSA-P).
We
retrospectively
reviewed
128
patients
who
underwent
multidisciplinary
team
(MDT)
intervention
at
Peking
Union
Medical
College
Hospital
between
March
31,
2021,
November
22,
2023.
A
total
16
PSP,
27
MSA-P,
11
PD
were
included.
Autonomic
was
assessed
using
SCOPA-AUT
scale
medical
record
data,
analyzed
with
IBM
SPSS
Statistics
26.
revealed
varying
degrees
across
all
groups.
The
score
lower
PSP
(16.88
±
6.70)
than
MSA-P
(23.33
8.80)
(p
=
0.019),
but
not
significantly
different
from
(18.64
9.80).
All
five
subscales
affected
though
significant
differences
found
only
urinary
control
0.006)
storage
0.008)
scores
MSA-P.
Orthostatic
hypotension
clinically
identified
7.7
%
66.7
27.3
patients,
a
difference
<
0.001).
Residual
urine
volume
(137.5
[75.5-190.25]
mL)
higher
(34.5
[1.50-60.00]
mL,
p
0.001)
(9.95
[1.13-56.25]
Our
findings
indicate
that
presents
various
forms
dysfunction,
as
by
SCOPA-AUT,
similarities
both
PD.
Objective
measures,
such
orthostatic
blood
pressure
assessments
residual
ultrasound,
can
provide
additional
insights
into
PSP.
Language: Английский
Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
Immunobiology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 152892 - 152892
Published: March 1, 2025
Progressive
supranuclear
palsy
(PSP)
is
a
neurodegenerative
disease
showing
pathological
tau
accumulation
in
subcortical
neurons
and
glial
cells.
The
human
leukocyte
antigen
(HLA)
locus
on
chromosome
6
polymorphic
region
with
complex
linkage
patterns
that
has
been
implicated
several
autoimmune
neurological
disorders.
HLA
not
systematically
examined
PSP.
It
unclear
whether
can
interact
to
induce
an
mechanism.
We
evaluated
autopsy
confirmed
PSP
cohort
(n
=
44)
compared
allele/haplotype
frequencies
those
of
the
reference
group
local
deceased
Canadian
donor
pool.
performed
HLA-Tau
peptide
binding
prediction
modelling
Class
II
-
Tau
Peptide
interactions.
Odds
ratio
was
2.94
(95
%
CI
1.01
8.55;
p
0.047)
for
DQB1*06:01
allele,
2.59
1.39
4.83;
0.0025)
narcolepsy-associated
haplotype
(DRB1*15:01-DQB1*06:02).
One
patient
4-repeat
PSP-type
pathology
carrier
IgLON5-associated
(DRB1*10:01-DQB1*05:01).
interactions
revealed
strong-binding
peptides
but
PSP-protofilament
fold
alleles
DQA1*01:02-DQB1*06:02
DQA1*01:03-DQB1*06:01.
Our
study
suggests
epitopes
within
may
bind
are
found
subset
patients
supporting
notion
pathophysiological
component.
These
findings
have
implications
subtyping
stratifying
therapies,
including
targeting
immune
modulation.
Language: Английский
Renalase Overexpression-Mediated Excessive Metabolism of Peripheral Dopamine, DOPAL Accumulation, and α-Synuclein Aggregation in Baroreflex Afferents Contribute to Neuronal Degeneration and Autonomic Dysfunction
Xue Xiong,
No information about this author
Yi Xu,
No information about this author
Yan Zhang
No information about this author
et al.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(5), P. 1243 - 1243
Published: May 20, 2025
Background/Objectives:
Increasing
evidence
reveals
the
likely
peripheral
etiology
of
Parkinson’s
disease;
however,
mechanistic
insight
into
α-Synuclein
aggregation
in
periphery
remains
unclear.
This
study
aimed
to
explore
effect
abnormal
expression
renalase
on
dopamine
metabolism,
toxic
DOPAL
generation,
and
subsequently,
aggregation.
Methods:
Blood
pressure
(BP)
was
monitored
while
changing
body
position
rats;
serum
level
detected
by
ELISA;
mRNA/protein
were
determined
qRT-PCR/Western
blot;
measured
using
HPLC;
distribution
explored
immunostaining;
cell
viability
ultrastructure
examined
TUNEL
electron
microscopy,
respectively.
Results:
The
results
showed
that,
PD
model
rats,
increased
time-dependently
with
up-regulated
gene/protein
nodose
ganglia,
nucleus
tractus
solitarius,
heart;
a
reduced
content
also
overexpression
PC12
cells.
Strikingly,
orthostatic
BP
changes
observed
before
behavior
rats.
Meanwhile,
levels
time-dependently.
Intriguingly,
low
molecular
weight
declined
coordinately
increase
higher
α-Synuclein.
Clear
damages
at
cellular
supported
notion
findings.
Notably,
aggregation-induced
impairment
axonal
transport
function
predates
neuronal
degeneration
mediated
overexpression.
Conclusions:
Our
demonstrate
that
metabolism
overexpressed
promotes
DOPAL-induced
leads
baroreflex
afferent
early
autonomic
failure.
Language: Английский